scispace - formally typeset
E

Evguenia Kopylova

Researcher at University of California, San Diego

Publications -  20
Citations -  6185

Evguenia Kopylova is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Ribosomal RNA & Genome. The author has an hindex of 12, co-authored 17 publications receiving 3951 citations. Previous affiliations of Evguenia Kopylova include University of Colorado Boulder & French Institute for Research in Computer Science and Automation.

Papers
More filters
Journal ArticleDOI

SortMeRNA: Fast and accurate filtering of ribosomal RNAs in metatranscriptomic data.

TL;DR: SortMeRNA, a new software designed to rapidly filter rRNA fragments from metatranscriptomic data, is presented, capable of handling large sets of reads and sorting out all fragments matching to the rRNA database with high sensitivity and low running time.
Journal ArticleDOI

A communal catalogue reveals Earth’s multiscale microbial diversity

TL;DR: A meta-analysis of microbial community samples collected by hundreds of researchers for the Earth Microbiome Project is presented, creating both a reference database giving global context to DNA sequence data and a framework for incorporating data from future studies, fostering increasingly complete characterization of Earth’s microbial diversity.
Journal ArticleDOI

Deblur Rapidly Resolves Single-Nucleotide Community Sequence Patterns

TL;DR: A novel sub-operational-taxonomic-unit (sOTU) approach that uses error profiles to obtain putative error-free sequences from Illumina MiSeq and HiSeq sequencing platforms, Deblur, which substantially reduces computational demands relative to similar sOTU methods and does so with similar or better sensitivity and specificity.
Journal ArticleDOI

Microbiome analyses of blood and tissues suggest cancer diagnostic approach

TL;DR: Microbial nucleic acids are detected in samples of tissues and blood from more than 10,000 patients with cancer, and machine learning is used to show that these can be used to discriminate between and among different types of cancer, suggesting a new microbiome-based diagnostic approach.